iksa began as an AI lab inside the leading regenerative medicine provider in East Asia
Iksa is short for “ikshana”, which means to provide care with the utmost sight. We build for the doctors who practice that way.
The group’s CEO and COO, on film · 2:38Watch the case study
Why we started
We came to this medicine from clinical trials, and what stayed with us was everything a trial builds around one protocol: the schedule, the monitoring, the watch for side effects, every change kept with its reason. Then we met doctors running protocols every bit as demanding for one patient at a time, and holding all of that together themselves.
So we went to work beside them. We built iksa inside a group where a plan is written for one person and carried out over years, and where the same clinic often cares for several generations of one family. The group’s doctors and nurses were in the room with us. We started with patients already in care, and then the nurses who carry their protocols every day.
How we work
- The doctor decides.
- We build for the person carrying the patient, and we’ve turned down work that would have put AI between pharma, doctors and patients.
- We learn in the room.
- We ask a clinic for its hardest patient, because that’s where we find out what we got wrong.
- We hold our words to the evidence.
- Nothing we ship reaches a clinic until it has passed its evals, and we say what the evidence shows and stop there.
- We’re in this for years.
- The patients we build for stay for years, and the people who advise us go back as far as fifteen years with us.
We go back over a decade across life sciences, enterprise software and healthcare
Our team and advisors have formed the platform with their depth and commitment.
Clinical and personalized medicine
We’ve cared for patients and studied how treatment fits the person.
Drug development and clinical trials
We’ve designed trials, run them and seen therapies through them to patients.
Life-sciences commercial and operations
We’ve planned, priced and launched therapies for the largest drug companies.
Data, AI and software at scale
We’ve built the data systems that clinical trials and genetic testing run on.
In the news
Talk to the team that builds the harness for n‑of‑1 medicine
Bring a protocol you run. We’ll walk one patient through it.


